• 1. Emergence of microfluidic wearable technologies
  Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090
• 2. Enabling stable MnO2 matrix for aqueous zinc-ion battery cathodes?
  Yiding Jiao,Liqun Kang,Jasper Berry-Gair,Kit McColl,Jianwei Li,Haobo Dong,Hao Jiang,Ryan Wang,Furio Corà,Dan J. L. Brett,Ivan P. Parkin J. Mater. Chem. A, 2020,8, 22075-22082
• 3. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477
• 4. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 5. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291

1,2,5-Tri-O-acetyl-3-deoxy-D-ribofuranose (CAS No. 865853-43-6): An Overview and Recent Advances

1,2,5-Tri-O-acetyl-3-deoxy-D-ribofuranose (CAS No. 865853-43-6) is a significant compound in the field of organic and medicinal chemistry. This compound is a derivative of D-ribofuranose, a five-carbon sugar that plays a crucial role in the structure of nucleic acids such as RNA. The acetylation of specific hydroxyl groups in D-ribofuranose to form 1,2,5-Tri-O-acetyl-3-deoxy-D-ribofuranose imparts unique chemical and biological properties, making it a valuable intermediate in the synthesis of various pharmaceuticals and biologically active molecules.

The structure of 1,2,5-Tri-O-acetyl-3-deoxy-D-ribofuranose consists of a five-membered furan ring with three acetyl groups attached to the 1, 2, and 5 positions. The 3-deoxy substitution removes the hydroxyl group at the 3-position, which can significantly alter the reactivity and stability of the molecule. This modification is particularly important in the context of nucleoside analogs and their applications in antiviral and anticancer therapies.

In recent years, there has been growing interest in the use of 1,2,5-Tri-O-acetyl-3-deoxy-D-ribofuranose as a building block for the synthesis of novel nucleoside analogs. These analogs are designed to mimic natural nucleosides but with enhanced pharmacological properties. For instance, studies have shown that certain derivatives of 1,2,5-Tri-O-acetyl-3-deoxy-D-ribofuranose exhibit potent antiviral activity against a range of viruses, including HIV and hepatitis C virus (HCV). The acetylated groups provide additional steric hindrance and electronic effects that can influence the binding affinity and selectivity of these analogs to their target enzymes.

Beyond antiviral applications, 1,2,5-Tri-O-acetyl-3-deoxy-D-ribofuranose has also been explored for its potential in cancer therapy. Research has demonstrated that certain derivatives can inhibit key enzymes involved in DNA synthesis and repair, thereby disrupting the proliferation of cancer cells. For example, a study published in the Journal of Medicinal Chemistry reported that a specific derivative of 1,2,5-Tri-O-acetyl-3-deoxy-D-ribofuranose showed significant cytotoxicity against several human cancer cell lines while exhibiting minimal toxicity to normal cells.

The synthesis of 1,2,5-Tri-O-acetyl-3-deoxy-D-ribofuranose typically involves multiple steps starting from commercially available D-ribulose or D-arabinose. The key steps include selective protection of hydroxyl groups followed by reduction and deprotection to achieve the desired acetylated derivative. Advances in synthetic methods have led to more efficient and scalable processes for producing this compound, making it more accessible for research and development purposes.

In addition to its direct applications in drug development, 1,2,5-Tri-O-acetyl-3-deoxy-D-ribofuranose serves as an important tool for studying carbohydrate chemistry and glycosylation processes. Its unique structure allows researchers to probe the effects of specific functional groups on molecular recognition and enzymatic activity. This knowledge can be applied to design more effective therapeutic agents and diagnostic tools.

The future prospects for 1,2,5-Tri-O-acetyl-3-deoxy-D-ribofuranose are promising. Ongoing research is focused on optimizing its derivatives for improved pharmacokinetic properties and reduced side effects. Additionally, there is increasing interest in exploring its potential as a prodrug or delivery platform for other bioactive molecules. As our understanding of carbohydrate chemistry continues to evolve, it is likely that new applications for this versatile compound will emerge.

In conclusion, 1,2,5-Tri-O-acetyl-3-deoxy-D-ribofuranose (CAS No. 865853-43-6) is a multifaceted compound with significant potential in various areas of medicinal chemistry. Its unique structural features make it an attractive candidate for developing novel therapeutics and advancing our understanding of biological processes involving carbohydrates. As research progresses, it is expected that this compound will continue to play a pivotal role in driving innovation in drug discovery and development.

• 13035-61-5(1,2,3,5-Tetra-O-acetyl b-D-Ribofuranose)
• 30571-56-3(1,2,3,5-Tetra-O-acetyl-D-xylofuranose)
• 144490-03-9(1,2,3,5-tetra-O-acetyl-Beta-L-ribofuranose)
• 79120-81-3(a-L-Arabinofuranose, tetraacetate(9CI))
• 844877-56-1(b-L-Xylofuranose, tetraacetate(9CI))
• 10535-09-8(Galactofuranose, pentaacetate(6CI,7CI,8CI))
• 28708-32-9((3R,4R,5R)-5-(Acetoxymethyl)tetrahydrofuran-2,3,4-triyl triacetate)
• 37076-71-4((3R,4R,5R)-5-Methyltetrahydrofuran-2,3,4-triyl triacetate)
• 43225-70-3(Mixture of 1,2,3,5-Tetra-O-acetyl-D-arabinofuranose and 1,2,3,4-Tetra-O-acetyl-D-arabinopyranose (α/β-mixture))
• 62211-93-2(1,2,3-Triacetyl-5-Deoxy-D-Ribose)